BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Oh BY, Lee RA, Kim KH. siRNA targeting Livin decreases tumor in a xenograft model for colon cancer. World J Gastroenterol 2011; 17(20): 2563-2571 [PMID: 21633662 DOI: 10.3748/wjg.v17.i20.2563]
URL: https://www.wjgnet.com/1007-9327/full/v17/i20/2563.htm
Number Citing Articles
1
Marco Mazzoletti, Gemma Texidó. Target Identification and Validation in Drug DiscoveryMethods in Molecular Biology 2013; 986: 325 doi: 10.1007/978-1-62703-311-4_20
2
Mohammed Faruk, Sani Ibrahim, Surajo Mohammed Aminu, Ahmed Adamu, Adamu Abdullahi, Aishatu Maude Suleiman, Abdulmumini Hassan Rafindadi, Abdullahi Mohammed, Yawale Iliyasu, John Idoko, Rakiya Saidu, Abdullahi Jibril Randawa, Halimatu Sadiya Musa, Atara Ntekim, Khalid Zahir Shah, Sani Abubakar, Kasimu Umar Adoke, Muhammad Manko, Cheh Agustin Awasum, Irina V. Lebedeva. Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirinPLOS ONE 2021; 16(1): e0245581 doi: 10.1371/journal.pone.0245581
3
Feng Wang, Wei He, Peng Fanghui, Liuxing Wang, Qingxia Fan. NF‐κBP65 promotes invasion and metastasis of oesophageal squamous cell cancer by regulating matrix metalloproteinase‐9 and epithelial‐to‐mesenchymal transitionCell Biology International 2013; 37(8): 780 doi: 10.1002/cbin.10089
4
Hao Xu, Shangjun Wu, Xin Shen, Zhan Shi, Ding Wu, Yuan Yuan, Wei Jiang, Qianliang Wang, Qin Ke, Qing Mao, Xianlong Li, Yong Liu, Pingcheng Yuan, Qinghan Zhang, Enying Huang, Xiaogang Chen. Methylation‐mediated miR‐214 regulates proliferation and drug sensitivity of renal cell carcinoma cells through targeting LIVINJournal of Cellular and Molecular Medicine 2020; 24(11): 6410 doi: 10.1111/jcmm.15287
5
Ziyad Binkhathlan, Aws Alshamsan. Emerging nanodelivery strategies of RNAi molecules for colon cancer therapy: preclinical developmentsTherapeutic Delivery 2012; 3(9): 1117 doi: 10.4155/tde.12.89
6
Barbara Altieri, Silviu Sbiera, Silvia Della Casa, Isabel Weigand, Vanessa Wild, Sonja Steinhauer, Guido Fadda, Arkadius Kocot, Michaela Bekteshi, Egle M. Mambretti, Andreas Rosenwald, Alfredo Pontecorvi, Martin Fassnacht, Cristina L. Ronchi. Livin/BIRC7 expression as malignancy marker in adrenocortical tumorsOncotarget 2017; 8(6): 9323 doi: 10.18632/oncotarget.14067
7
SANG-WON HONG, KYUNG HEE JUNG, MYUNG-JOO CHOI, DA YOUNG KIM, HEE-SEUNG LEE, HONG-MEI ZHENG, GUANG YONG LI, IBRAHIM M. EL-DEEB, BYUNG SUN PARK, SO HA LEE, SOON-SUN HONG. Anticancer effects of KI-10F: A novel compound affecting apoptosis, angiogenesis and cell growth in colon cancerInternational Journal of Oncology 2012; 41(5): 1715 doi: 10.3892/ijo.2012.1609
8
Darren Finlay, Peter Teriete, Mitchell Vamos, Nicholas D. P. Cosford, Kristiina Vuori. Inducing death in tumor cells: roles of the inhibitor of apoptosis proteinsF1000Research 2017; 6: 587 doi: 10.12688/f1000research.10625.1
9
Asiyeh Jebelli, Behzad Baradaran, Jafar Mosafer, Amir Baghbanzadeh, Ahad Mokhtarzadeh, Lobat Tayebi. Recent developments in targeting genes and pathways by RNAi‐based approaches in colorectal cancerMedicinal Research Reviews 2021; 41(1): 395 doi: 10.1002/med.21735
10
A. Deezagi, S. Ansari-Majd, N. Vaseli-Hagh. Induced apoptosis in human prostate cancer cells by blocking of vascular endothelial growth factor by siRNAClinical and Translational Oncology 2012; 14(10): 791 doi: 10.1007/s12094-012-0868-1
11
Gang Li, Hong Chang, Yun-Peng Zhai, Wei Xu. Targeted Silencing of Inhibitors of Apoptosis Proteins with siRNAs: A Potential Anti-cancer Strategy for Hepatocellular CarcinomaAsian Pacific Journal of Cancer Prevention 2013; 14(9): 4943 doi: 10.7314/APJCP.2013.14.9.4943
12
Gemma Texidó. Target Identification and Validation in Drug DiscoveryMethods in Molecular Biology 2013; 986: 281 doi: 10.1007/978-1-62703-311-4_18
13
Dae-Seong Myung, Young-Lan Park, Cho-Yun Chung, Hyung-Chul Park, Jong-Sun Kim, Sung-Bum Cho, Wan-Sik Lee, Kyung-Hwa Lee, Jae-Hyuk Lee, Young-Eun Joo, DunFa Peng. Expression of Livin in Colorectal Cancer and Its Relationship to Tumor Cell Behavior and PrognosisPLoS ONE 2013; 8(9): e73262 doi: 10.1371/journal.pone.0073262
14
Bo Young Oh, Kwang Ho Kim, Soon Sup Chung, Ryung-Ah Lee. Silencing thelivingene enhances the cytotoxic effects of anticancer drugs on colon cancer cellsAnnals of Surgical Treatment and Research 2016; 91(6): 273 doi: 10.4174/astr.2016.91.6.273
15
Jiequn Li, Zhulin Yang, Shengfu Huang, Daiqiang Li. BIRC7 and STC2 Expression Are Associated With Tumorigenesis and Poor Outcome in Extrahepatic CholangiocarcinomaTechnology in Cancer Research & Treatment 2020; 19: 153303382097167 doi: 10.1177/1533033820971676
16
Wei Xu, Hong Chang, Cheng-Kun Qin, Yun-Peng Zhai. Impact of Co-transfection with Livin and Survivin shRNA Expression Vectors on Biological Behavior of HepG2 CellsAsian Pacific Journal of Cancer Prevention 2013; 14(9): 5467 doi: 10.7314/APJCP.2013.14.9.5467
17
Ömer Güllülü, Stephanie Hehlgans, Claus Rödel, Emmanouil Fokas, Franz Rödel. Tumor Suppressor Protein p53 and Inhibitor of Apoptosis Proteins in Colorectal Cancer—A Promising Signaling Network for Therapeutic InterventionsCancers 2021; 13(4): 624 doi: 10.3390/cancers13040624
18
Nagindra Prashad. Pheochromocytoma, Paraganglioma and Neuroblastoma2021;  doi: 10.5772/intechopen.96021